Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud

Ivermectin has become a controversial potential medicine for coronavirus disease 2019. Some early studies suggested clinical benefits in treatment of infection. However, the body of evidence includes studies of varying quality. Furthermore, some trials have now been identified as potentially fraudul...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Andrew, Mirchandani, Manya, Pilkington, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774052/
https://www.ncbi.nlm.nih.gov/pubmed/35071686
http://dx.doi.org/10.1093/ofid/ofab645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774052/
https://www.ncbi.nlm.nih.gov/pubmed/35071686
http://dx.doi.org/10.1093/ofid/ofab645

Ejemplares similares